her and her doctor are suspecting that this could be a breakthrough covid; nose runs; she has issues with breathing, more like sinus; sleep apnea; breathing, more like sinus; diarrhea aggravated; chills; nausea aggravated; vomiting aggravated; slight headache/ headache that was boozy; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (her and her doctor are suspecting that this could be a breakthrough covid), RHINORRHOEA (nose runs), DYSPNOEA (she has issues with breathing, more like sinus), SLEEP APNOEA SYNDROME (sleep apnea) and SINUSITIS (breathing, more like sinus) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 007B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sleep apnea from 05-Nov-2019 to 19-Oct-2021. Previously administered products included for Product used for unknown indication: Influenza (route is injection and body site is left arm) on 12-Oct-2021. Past adverse reactions to the above products included No adverse event with Influenza. Concurrent medical conditions included Autoimmune disorder NOS since October 2021, Contrast media allergy, Drug allergy (Morphine), Drug allergy (Fosamax), Drug allergy (Glucosamine condrotin), Allergy to antibiotic (Cefdinir), Blood pressure high since 1996, High cholesterol since 2000, Depression since 1985, Fibromyalgia since 1993, Lupus-like syndrome since October 2021 and Allergy to antibiotic (Cillins). Concomitant products included AMLODIPINE, METOPROLOL, LOSARTAN, ASPIRIN [ACETYLSALICYLIC ACID], MULTIVITAMIN [VITAMINS NOS], LACTOBACILLUS ACIDOPHILUS (ACIDOPHILUS [LACTOBACILLUS ACIDOPHILUS]), BUSPIRONE HYDROCHLORIDE (BUSPAR), CALCIUM, VITAMIN K [VITAMIN K NOS], UBIDECARENONE (COQ10 [UBIDECARENONE]), VITAMIN D NOS, PRAVASTATIN, CELECOXIB (CELEBREX) and ESCITALOPRAM for an unknown indication.   On 10-Mar-2021 at 3:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021 at 2:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 11:15 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (her and her doctor are suspecting that this could be a breakthrough covid), RHINORRHOEA (nose runs), DYSPNOEA (she has issues with breathing, more like sinus), SLEEP APNOEA SYNDROME (sleep apnea), SINUSITIS (breathing, more like sinus), DIARRHOEA (diarrhea aggravated), CHILLS (chills), NAUSEA (nausea aggravated), VOMITING (vomiting aggravated), HEADACHE (slight headache/ headache that was boozy) and FATIGUE (fatigue). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, SUSPECTED COVID-19 (her and her doctor are suspecting that this could be a breakthrough covid), RHINORRHOEA (nose runs), DYSPNOEA (she has issues with breathing, more like sinus), SLEEP APNOEA SYNDROME (sleep apnea), SINUSITIS (breathing, more like sinus) and FATIGUE (fatigue) outcome was unknown and DIARRHOEA (diarrhea aggravated), CHILLS (chills), NAUSEA (nausea aggravated), VOMITING (vomiting aggravated) and HEADACHE (slight headache/ headache that was boozy) had not resolved.            Suspected COVID 19 infection is reported by the patient. As reported by the patient that she cannot take anymore so patient made appointment with her doctor on 4-Sep-2021. Patient also had blood work which resulted in the diagnosis of sleep apnea and lupus and she also stated that being on CPAP the headaches were less severe.  This is a Spontaneous case concerning a 68-year-old, female patient with medical history of sleep apnea, multiple allergies, hypertension, high cholesterol, depression, fibromyalgia and lupus like syndrome, who experienced the unexpected non serious (AESI) event of suspected COVID 19 among other expected and non expected non serious events.. The event occurred after the third dose of mRNA 1273 vaccine. The event wasn't confirmed by the health care practitioner.  The medical history of fibromyalgia and lupus like syndrome are confounders for the event.   The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.   This case was linked to MOD-2021-390889 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: Updated contact information, event outcome changed for diarrhea, chills, nausea, vomiting and headache from unknown to not recovered. On 23-Nov-2021: Patient demographic details, medical history, allergic condition and concomitant medications were added.; Sender's Comments: This is a Spontaneous case concerning a 68-year-old, female patient with medical history of sleep apnea, multiple allergies, hypertension, high cholesterol, depression, fibromyalgia and lupus like syndrome, who experienced the unexpected non serious (AESI) event of suspected COVID 19 among other expected and non expected non serious events.. The event occurred after the third dose of mRNA 1273 vaccine. The event wasn't confirmed by the health care practitioner.  The medical history of fibromyalgia and lupus like syndrome are confounders for the event.   The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.